Matches in SemOpenAlex for { <https://semopenalex.org/work/W2257285030> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2257285030 endingPage "9" @default.
- W2257285030 startingPage "314" @default.
- W2257285030 abstract "Lansoprazole, a new proton pump inhibitor, is now available in Mexico. It has been tested elsewhere with excellent results.To study its safety and efficacy in Mexican patients.40 patients with gastric or duodenal ulcer larger than 0.5 cm, from 4 hospitals in central Mexico, were included. All were subjected to a complete medical history and upper GI endoscopy. symptoms (epigastric pain, heartburn, regurgitation, nausea, vomiting) were graded 1 to 4 according to severity. Lansoprazole (one 30 mg capsule/ day) was prescribed for 4 weeks in duodenal ulcer 8 weeks in gastric ulcer. Each patient was seen once a week at the office for compliance, symptom evaluation and side effects. A second endoscopy was performed at the end of the respective treatment period. Blood (CBC, chemistries) and urine tests were performed at the beginning and end of the study.23 men and 17 women were included, Mean age: 53.8 yr. (19-95). 11 gastric ulcers and 29 duodenal ulcers. 27 measured 0.6-1.5 cm; 6 ulcers measured 1.6-2.5 cm; 6 ulcers were larger than 2.5 cm. 8 patients were bleeding at admission and 4 had multiple ulcers. 2 patients were lost to follow up. symptom grading: 18 patients had 10 points or less, 21 had more than 10 points, one bleeding patient was otherwise asymptomatic. After the first week of treatment, 42% were asymptomatic, after the 2nd. week, 75% were asymptomatic and 95% at the end of the study. The second endoscopy documented complete ulcer healing in 92% out of 37 remaining patients; further lansoprazole treatment healed 2 out of three unhealed ulcers. One patient underwent surgery for duodenal bulb stenosis. Side effects were reported by 2 patients. Treatment had to be discontinued in one patient because of headache. There was no effect of lansoprazole over the laboratory tests.Lansoprazole was effective for prompt symptom relief in most patients and was able to heal more than 90% of gastric and duodenal ulcers with minimal side effects." @default.
- W2257285030 created "2016-06-24" @default.
- W2257285030 creator A5000404397 @default.
- W2257285030 creator A5041506547 @default.
- W2257285030 creator A5047850780 @default.
- W2257285030 creator A5048156016 @default.
- W2257285030 creator A5077430581 @default.
- W2257285030 date "1996-10-01" @default.
- W2257285030 modified "2023-09-23" @default.
- W2257285030 title "[Effectiveness and safety of lansoprazole in the treatment of peptic ulcer]." @default.
- W2257285030 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9072782" @default.
- W2257285030 hasPublicationYear "1996" @default.
- W2257285030 type Work @default.
- W2257285030 sameAs 2257285030 @default.
- W2257285030 citedByCount "0" @default.
- W2257285030 crossrefType "journal-article" @default.
- W2257285030 hasAuthorship W2257285030A5000404397 @default.
- W2257285030 hasAuthorship W2257285030A5041506547 @default.
- W2257285030 hasAuthorship W2257285030A5047850780 @default.
- W2257285030 hasAuthorship W2257285030A5048156016 @default.
- W2257285030 hasAuthorship W2257285030A5077430581 @default.
- W2257285030 hasConcept C126322002 @default.
- W2257285030 hasConcept C141071460 @default.
- W2257285030 hasConcept C2776409635 @default.
- W2257285030 hasConcept C2776462128 @default.
- W2257285030 hasConcept C2777910003 @default.
- W2257285030 hasConcept C2778451229 @default.
- W2257285030 hasConcept C2778715759 @default.
- W2257285030 hasConcept C2779134260 @default.
- W2257285030 hasConcept C2780580376 @default.
- W2257285030 hasConcept C2780852908 @default.
- W2257285030 hasConcept C2781025758 @default.
- W2257285030 hasConcept C2991960855 @default.
- W2257285030 hasConcept C43270747 @default.
- W2257285030 hasConcept C71924100 @default.
- W2257285030 hasConcept C90924648 @default.
- W2257285030 hasConceptScore W2257285030C126322002 @default.
- W2257285030 hasConceptScore W2257285030C141071460 @default.
- W2257285030 hasConceptScore W2257285030C2776409635 @default.
- W2257285030 hasConceptScore W2257285030C2776462128 @default.
- W2257285030 hasConceptScore W2257285030C2777910003 @default.
- W2257285030 hasConceptScore W2257285030C2778451229 @default.
- W2257285030 hasConceptScore W2257285030C2778715759 @default.
- W2257285030 hasConceptScore W2257285030C2779134260 @default.
- W2257285030 hasConceptScore W2257285030C2780580376 @default.
- W2257285030 hasConceptScore W2257285030C2780852908 @default.
- W2257285030 hasConceptScore W2257285030C2781025758 @default.
- W2257285030 hasConceptScore W2257285030C2991960855 @default.
- W2257285030 hasConceptScore W2257285030C43270747 @default.
- W2257285030 hasConceptScore W2257285030C71924100 @default.
- W2257285030 hasConceptScore W2257285030C90924648 @default.
- W2257285030 hasIssue "4" @default.
- W2257285030 hasLocation W22572850301 @default.
- W2257285030 hasOpenAccess W2257285030 @default.
- W2257285030 hasPrimaryLocation W22572850301 @default.
- W2257285030 hasRelatedWork W184679582 @default.
- W2257285030 hasRelatedWork W197370031 @default.
- W2257285030 hasRelatedWork W2012641473 @default.
- W2257285030 hasRelatedWork W2037597130 @default.
- W2257285030 hasRelatedWork W2088007605 @default.
- W2257285030 hasRelatedWork W2104087755 @default.
- W2257285030 hasRelatedWork W2153087976 @default.
- W2257285030 hasRelatedWork W2380051598 @default.
- W2257285030 hasRelatedWork W2414274834 @default.
- W2257285030 hasRelatedWork W3146917928 @default.
- W2257285030 hasVolume "61" @default.
- W2257285030 isParatext "false" @default.
- W2257285030 isRetracted "false" @default.
- W2257285030 magId "2257285030" @default.
- W2257285030 workType "article" @default.